Dr Louis Chesler
Research Interests
Dr Chesler is Team Leader of the Neuroblastoma Drug Development Team in the Section of Paediatric Oncology. His team has several key objectives, including:
- Understand the role of the MYCN oncogene in neuroblastoma, and in other childhood solid tumors in which aberrations of MYCN expression occur (medulloblastoma, rhabdomyosarcoma)
- Develop novel onco-therapeutics targeting MYCN and its oncoprotein
- Develop refined preclinical platforms for efficient development of novel therapeutics for neuroblastoma
- Develop and functionally validate optical imaging modalities for use as surrogate markers of tumour progression
View Publications from Dr Louis Chesler.
Find out more about Dr Chesler in the ICR’s News Section.
